| Year |
Citation |
Score |
| 2016 |
Luo Y, Jacobs EY, Greco TM, Mohammed KD, Tong T, Keegan S, Binley JM, Cristea IM, Fenyö D, Rout MP, Chait BT, Muesing MA. HIV-host interactome revealed directly from infected cells. Nature Microbiology. 1: 16068. PMID 27572969 DOI: 10.1038/nmicrobiol.2016.68 |
0.508 |
|
| 2016 |
Luo Y, Jacobs EY, Greco TM, Mohammed KD, Tong T, Keegan S, Binley JM, Cristea IM, Fenyö D, Rout MP, Chait BT, Muesing MA. HIV-host interactome revealed directly from infected cells. Nature Microbiology. 1. PMID 27375898 DOI: 10.1038/Nmicrobiol.2016.68 |
0.558 |
|
| 2014 |
Luo Y, Muesing MA. Mass spectrometry-based proteomic approaches for discovery of HIV-host interactions. Future Virology. 9: 979-992. PMID 25544858 DOI: 10.2217/Fvl.14.86 |
0.523 |
|
| 2014 |
Trinité B, Chan CN, Lee CS, Mahajan S, Luo Y, Muesing MA, Folkvord JM, Pham M, Connick E, Levy DN. Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells. Plos One. 9: e110719. PMID 25330112 DOI: 10.1371/Journal.Pone.0110719 |
0.526 |
|
| 2011 |
Sargeant D, Deverasetty S, Luo Y, Villahoz Baleta A, Zobrist S, Rathnayake V, Russo JC, Vyas J, Muesing MA, Schiller MR. HIVToolbox, an integrated web application for investigating HIV. Plos One. 6: e20122. PMID 21647445 DOI: 10.1371/Journal.Pone.0020122 |
0.502 |
|
| 2011 |
Mohammed KD, Topper MB, Muesing MA. Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. Journal of Virology. 85: 4654-66. PMID 21367893 DOI: 10.1128/Jvi.02374-10 |
0.553 |
|
| 2010 |
Luo Y, Muesing MA. Prospective strategies for targeting HIV-1 integrase function. Future Medicinal Chemistry. 2: 1055-60. PMID 21359091 DOI: 10.4155/fmc.10.205 |
0.568 |
|
| 2009 |
Low A, Prada N, Topper M, Vaida F, Castor D, Mohri H, Hazuda D, Muesing M, Markowitz M. Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors. Antimicrobial Agents and Chemotherapy. 53: 4275-82. PMID 19651917 DOI: 10.1128/Aac.00397-09 |
0.515 |
|
| 2007 |
Berthoux L, Sebastian S, Muesing MA, Luban J. The role of lysine 186 in HIV-1 integrase multimerization. Virology. 364: 227-36. PMID 17397894 DOI: 10.1016/J.Virol.2007.02.029 |
0.56 |
|
| 2007 |
Topper M, Luo Y, Zhadina M, Mohammed K, Smith L, Muesing MA. Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication. Journal of Virology. 81: 3012-7. PMID 17182677 DOI: 10.1128/Jvi.02257-06 |
0.521 |
|
| 2007 |
Lloyd AG, Ng YS, Muesing MA, Simon V, Mulder LCF. Characterization of HIV-1 integrase N-terminal mutant viruses Virology. 360: 129-135. PMID 17109911 DOI: 10.1016/J.Virol.2006.10.007 |
0.634 |
|
| 2006 |
Lloyd AG, Tateishi S, Bieniasz PD, Muesing MA, Yamaizumi M, Mulder LC. Effect of DNA repair protein Rad18 on viral infection. Plos Pathogens. 2: e40. PMID 16710452 DOI: 10.1371/Journal.Ppat.0020040 |
0.413 |
|
| 2005 |
Tasaki T, Mulder LC, Iwamatsu A, Lee MJ, Davydov IV, Varshavsky A, Muesing M, Kwon YT. A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. Molecular and Cellular Biology. 25: 7120-36. PMID 16055722 DOI: 10.1128/Mcb.25.16.7120-7136.2005 |
0.323 |
|
| 2003 |
Fischer M, Trkola A, Joos B, Hafner R, Joller H, Muesing MA, Kaufman DR, Berli E, Hirschel B, Weber R, Günthard HF. Shifts in cell-associated HIV-1 RNA but not in episomal HIV-1 DNA correlate with new cycles of HIV-1 infection in vivo Antiviral Therapy. 8: 97-104. PMID 12741621 |
0.615 |
|
| 2002 |
Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, Bieniasz PD. Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proceedings of the National Academy of Sciences of the United States of America. 99: 11914-9. PMID 12154227 DOI: 10.1073/Pnas.162299499 |
0.493 |
|
| 2002 |
Mulder LC, Chakrabarti LA, Muesing MA. Interaction of HIV-1 integrase with DNA repair protein hRad18. The Journal of Biological Chemistry. 277: 27489-93. PMID 12016221 DOI: 10.1074/Jbc.M203061200 |
0.595 |
|
| 2000 |
Mulder LCF, Muesing MA. Degradation of HIV-1 Integrase by the N-end Rule Pathway Journal of Biological Chemistry. 275: 29749-29753. PMID 10893419 DOI: 10.1074/Jbc.M004670200 |
0.56 |
|
| 1997 |
Kaldor SW, Kalish VJ, Davies JF, Shetty BV, Fritz JE, Appelt K, Burgess JA, Campanale KM, Chirgadze NY, Clawson DK, Dressman BA, Hatch SD, Khalil DA, Kosa MB, Lubbehusen PP, ... Muesing MA, et al. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. Journal of Medicinal Chemistry. 40: 3979-85. PMID 9397180 DOI: 10.1021/Jm9704098 |
0.515 |
|
| 1997 |
Fletcher TM, Soares MA, McPhearson S, Hui H, Wiskerchen M, Muesing MA, Shaw GM, Leavitt AD, Boeke JD, Hahn BH. Complementation of integrase function in HIV-1 virions. The Embo Journal. 16: 5123-38. PMID 9305653 DOI: 10.1093/Emboj/16.16.5123 |
0.653 |
|
| 1996 |
Jungheim LN, Shepherd TA, Baxter AJ, Burgess J, Hatch SD, Lubbehusen P, Wiskerchen M, Muesing MA. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands Journal of Medicinal Chemistry. 39: 96-108. PMID 8568831 DOI: 10.1021/Jm950576C |
0.492 |
|
| Show low-probability matches. |